Qing-xin Wang

Jiangsu Key Laboratory For High Technology Research Of TCM Formulae
Nanjing, 210023, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Discovery of 1-(Phenylsulfonyl)-1,2,3,4-tetrahydroquinoline Derivative as Orally Bioavailable and Safe RORγt Inverse Agonists for Potential Treatment of Rheumatoid Arthritis.

Discovery of 1-(Phenylsulfonyl)-1,2,3,4-tetrahydroquinoline Derivative as Orally Bioavailable and Safe RORγt Inverse Agonists for Potential Treatment of Rheumatoid Arthritis.

Journal: Journal of medicinal chemistry

Published: November 15, 2024

Design, Synthesis, and Biological Activities Evaluation of Type I FLT3 Inhibitors for the Treatment of Acute Myeloid Leukemia.

Design, Synthesis, and Biological Activities Evaluation of Type I FLT3 Inhibitors for the Treatment of Acute Myeloid Leukemia.

Journal: Drug development research

Published: July 24, 2024

Correction to "Discovery of RORγ Allosteric Fluorescent Probes and Their Application: Fluorescence Polarization, Screening, and Bioimaging".

Correction to "Discovery of RORγ Allosteric Fluorescent Probes and Their Application: Fluorescence Polarization, Screening, and Bioimaging".

Journal: Journal of medicinal chemistry

Published: March 26, 2024

Unraveling the Promise of RET Inhibitors in Precision Cancer Therapy by Targeting RET Mutations.

Unraveling the Promise of RET Inhibitors in Precision Cancer Therapy by Targeting RET Mutations.

Journal: Journal of medicinal chemistry

Published: March 14, 2024

Discovery of RORγ Allosteric Fluorescent Probes and Their Application: Fluorescence Polarization, Screening, and Bioimaging.

Discovery of RORγ Allosteric Fluorescent Probes and Their Application: Fluorescence Polarization, Screening, and Bioimaging.

Journal: Journal of medicinal chemistry

Published: March 05, 2024

Exploring drug repositioning possibilities of kinase inhibitors via molecular simulation.

Exploring drug repositioning possibilities of kinase inhibitors via molecular simulation.

Journal: Molecular informatics

Published: December 06, 2023

Preclinical characterization of danatinib as a novel FLT3 inhibitor with excellent efficacy against resistant acute myeloid leukemia.

Preclinical characterization of danatinib as a novel FLT3 inhibitor with excellent efficacy against resistant acute myeloid leukemia.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: August 14, 2023

Natural products as potential lead compounds to develop new antiviral drugs over the past decade.

Natural products as potential lead compounds to develop new antiviral drugs over the past decade.

Journal: European journal of medicinal chemistry

Published: April 13, 2023

Challenges for the development of mutant isocitrate dehydrogenases 1 inhibitors to treat glioma.

Challenges for the development of mutant isocitrate dehydrogenases 1 inhibitors to treat glioma.

Journal: European journal of medicinal chemistry

Published: March 16, 2023

Design and synthesis of selective FLT3 inhibitors via exploration of back pocket II.

Design and synthesis of selective FLT3 inhibitors via exploration of back pocket II.

Journal: Future medicinal chemistry

Published: January 18, 2023

Discovery of 4-(4-aminophenyl)-6-phenylisoxazolo[3,4-b]pyridine-3-amine derivatives as novel FLT3 covalent inhibitors for the intervention of acute myeloid leukemia.

Discovery of 4-(4-aminophenyl)-6-phenylisoxazolo[3,4-b]pyridine-3-amine derivatives as novel FLT3 covalent inhibitors for the intervention of acute myeloid leukemia.

Journal: Drug development research

Published: November 23, 2022

Showing 1-11 of 11

Last Updated: 09/26/2026